tm
Seeing Is Believing
tm
Seeing Is Believing
ARDS is currently covered by 2 analysts
Aridis Pharmaceuticals's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of ARDS is 100% BUY.
Highest price target for ARDS is $1, Lowest price target is $1.
Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 23-Nov-2022. First documented stock forecast 10-Sep-2018.
Currently out of the existing stock ratings of ARDS, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$2
$1.92 (2400.00%)
$10
3 years 10 months 13 days ago
(23-Nov-2022)
0/3 (0%)
$1.1 (122.22%)
Buy
$25
$24.93 (35614.29%)
$25
6 years 8 months 10 days ago
(27-Jan-2020)
0/2 (0%)
$18.21 (268.19%)
Which analyst most recently updated their price target on ARDS (Aridis Pharmaceuticals)?
Which analyst has the current lower performing score on ARDS (Aridis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARDS (Aridis Pharmaceuticals)?
Which analyst is the currently most bullish on ARDS (Aridis Pharmaceuticals)?
Which analyst is the currently most reserved on ARDS (Aridis Pharmaceuticals)?
